Trial intelligence / Profile preview

Prophylactic Anti-fungal Treatment in Severe Sepsis with Perforations

NCT02941068Phase 2Completed

Sponsor
General Hospital of Eastern Military Command
Start
Mar 2012
Primary completion
Jun 2016
Modality
Cyclic Peptides, Antimicrobial Peptides, Orthosteric Ligands
01

Overview

A Phase 2 trial of fluconazole, caspofungin in fungal infection, sponsored by General Hospital of Eastern Military Command. Started Mar 2012; status: completed.

02

Drugs

fluconazolecaspofungin
03

Conditions

fungal infection

Beyond the preview

Go deeper on NCT02941068.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02941068.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call